Financial Gravity Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Financial Gravity Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$116K	Hold	1	–	–	0.08%	265
2019 Q3	$0	Hold	1	–	–	﹤0.01%	1715
2019 Q2	$0	Hold	1	–	–	﹤0.01%	1853
2019 Q1	$0	Buy	+1	New	+$82	﹤0.01%	1645
2018 Q3	$0	Hold	2	–	–	﹤0.01%	1735
2018 Q2	$0	Buy	2 +1	+100%	+$86	﹤0.01%	1737
2018 Q1	$0	Buy	+1	New	+$81	﹤0.01%	1571

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Financial Gravity Asset Management's CBPO Position: Q4 2019 in Review

Financial Gravity Asset Management held its China Biologic Products Holdings, Inc. (CBPO) position steady in Q4 2019 at 1 share worth $116K. The position accounts for 0.08% of the portfolio, ranked #265.

Financial Gravity Asset Management first reported a position in CBPO in Q1 2018 and has held it in 7 quarters since. 87 funds tracked by Wall St. Rank hold CBPO as of Q4 2019.

Financial Gravity Asset Management held 1 share of China Biologic Products Holdings, Inc. worth $116K as of Q4 2019.
Financial Gravity Asset Management left its China Biologic Products Holdings, Inc. share count unchanged in Q4 2019.
China Biologic Products Holdings, Inc. made up 0.08% of Financial Gravity Asset Management's portfolio in Q4 2019, its #265 holding.
Financial Gravity Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2018 and has held it in 7 quarters since.
87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.